The Opioid Crisis Changed the Conversation Around Pain Care

The opioid crisis changed far more than prescribing practices. It changed how healthcare systems think about pain itself. For years, pain care discussions often centered primarily on immediate symptom control. But as opioid related harms increased across the United States, providers, policymakers, public health leaders, and patients began reevaluating how recovery and pain management should evolve over the long term.

According to the CDC, opioid involved overdose deaths rose significantly between 1999 and 2023, contributing to a broader national focus on prevention, recovery, education, and expanded non-opioid care pathways.

The future of pain care will likely involve more tools, more personalization, and more recovery focused coordination.

As the healthcare system searched for additional tools, interest grew in rehabilitation, physical therapy, behavioral health, recovery focused care, wearable therapeutics, non-pharmacologic interventions, and connected recovery systems. No single approach is sufficient for every patient or every condition. But expanding the number of evidence based options available to patients and providers has become an important healthcare priority.

Electrome's initial commercial focus is grounded in FDA cleared bioelectric therapy technology for pain and recovery applications. The company's broader platform vision is larger, building connected infrastructure that combines wearable therapeutics, provider workflows, AI assisted engagement, recovery intelligence, educational systems, and future signal discovery. The goal is not to replace all existing pain care approaches. It is to help expand and modernize the recovery ecosystem.